Versant Capital Management, Inc Blueprint Medicines Corp Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 47 shares of BPMC stock, worth $4,786. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 73
35.62%
Holding current value
$4,786
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BPMC
# of Institutions
394Shares Held
61.2MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$690 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$578 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$255 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$198 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...